The annual meeting of the EPAD European project took place in Amsterdam, from May 23rd to 25th
The new Barcelonaβeta Dementia Prevention Research Clinic plans to incorporate 400 people between 60 and 80 years who have noticed that they begin to have cognitive difficulties.
The studies will analyze the efficacy of various pharmacological treatments designed to act before the manifestation of the clinical symptoms of the disease.
Dr. José Luís Molinuevo from BBRC is part of the experts’ team that worked on the new research framework for Alzheimer’s disease definition, which has been published in Alzheimer's & Dementia Journal
It is the largest neuroimaging study conducted in healthy individuals who carry the APOE-Ɛ4 gene variant, which confers risk for developing Alzheimer’s disease
The project has received funding from the European Union’s Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie action grant agreement No 752310.
An international delegation from the Global Brain Health Institute (GBHI) visited the BBRC to explore possible collaborations in the field of dementia training
The study was carried out based on the data obtained in the epidemiological questionnaires responded by the participants of the Alfa Study
BBRC researchers made 4 oral presentations and exhibited 7 posters